http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6093746-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4607880b9a6d7543bf0cb5083a3b4de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ac64035439b1cf699854a3ef66a675e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
filingDate 1998-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_227d5e2582eb958da70b65002d13bbe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50de2b6887fbe175237acc448618a63c
publicationDate 2000-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6093746-A
titleOfInvention Therapeutic agents for asthma
abstract An object of the present invention is to provide safe therapeutic agents for asthma inhibiting the delayed type asthmatic reaction in bronchial asthma and having no side effect. The present invention is a therapeutic agents for asthma containing a compound represented by the under chemical formula or a physiologically acceptable base thereof as an effective ingredient, and the drug containing creatine or a physiologically acceptable base thereof as an effective ingredient. ##STR1##
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007203076-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757347-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013069764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011056091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10531680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010074591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003212136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011172306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009137669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8506989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833427-B2
priorityDate 1997-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5612375-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54368243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127774712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128530096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129409403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393795

Total number of triples: 52.